@raoult_didier Pourquoi passer sous silence les thérapeutiques à base d'#interferon. https://t.co/OKXej7TE7j https://t.co/TMgnPmx52r
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
RT @ColbyBrady: Better results than Remdesivir. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatme…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @WesElyMD: JAMA & Lancet: #Covid will be conquered incrementally, as in ‘90s w HIV. #JAMA figure https://t.co/nyeV13OLCI below to 👀 wher…
RT @WesElyMD: JAMA & Lancet: #Covid will be conquered incrementally, as in ‘90s w HIV. #JAMA figure https://t.co/nyeV13OLCI below to 👀 wher…
RT @WesElyMD: JAMA & Lancet: #Covid will be conquered incrementally, as in ‘90s w HIV. #JAMA figure https://t.co/nyeV13OLCI below to 👀 wher…
RT @WesElyMD: JAMA & Lancet: #Covid will be conquered incrementally, as in ‘90s w HIV. #JAMA figure https://t.co/nyeV13OLCI below to 👀 wher…
Interferon & #Covid - May help by creating “Social Distancing” between cells & virus inside our body. Anti-SARS-CoV activity related to instigating apoptosis (programmed cell death) for infected cells and helping un-infected cells remain safe. Nee
RT @WesElyMD: JAMA & Lancet: #Covid will be conquered incrementally, as in ‘90s w HIV. #JAMA figure https://t.co/nyeV13OLCI below to 👀 wher…
JAMA & Lancet: #Covid will be conquered incrementally, as in ‘90s w HIV. #JAMA figure https://t.co/nyeV13OLCI below to 👀 where triple drugs hit. #Lancet study https://t.co/rQ3Dhj40a0 is small & open label yet we learn. ~4 days less viral shedding a
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/K6goZrGgfZ
Though not blinded and the cohort had mild to moderate #Covid_19, but results are quite good in the triple therapy Vs control
COVID-19 CORONAVIRUS DISEASE PANDEMIC / RESEARCH INTO DRUG TREATMENTS FOR COVID-19 / HONG KONG TRIPLE COMBINATION DRUG TRIAL STUDY (https://t.co/cRZLvkeuP7, https://t.co/WqQnYI4cwj):
Triple antiviral therapy with #IFN beta1b, #lopinavir-#ritonavir, and #ribavirin were safe and superior to lopinavir–ritonavir alone in shortening virus shedding, alleviating symptoms, and facilitating discharge of patients with mild to moderate #COVID19
😷 [Articles] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial 👉 https://t.co/zEgz8JNX9t 💊 #Medical #GroupZirigoza
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/2gJ8YT2XSN
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @JorgeMTamayo: Terapia triple con interferon beta-1b, lopinavir–ritonavir (L-R) y ribavirina fue segura y superior al L-R solo para redu…
RT @jorroser: Evidencia de que debemos replantear la terapia contra el COVID19, entre más rápido al inicio de los síntomas mejor. Opcione…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/ducw1sKybS
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
RT @jvillacastin: COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple…
COVID 19: en 121 pac. (51a.) con enfermedad ligera moderada, tratados a los 5 días de inicio de los síntomas, esta triple terapia comparada con la doble, acelera el tiempo de desaparición del virus. No hubo mortalidad en el estudio ni tampoco grupo placebo
RT @AbdTahrani: Early triple antiviral therapy shortened the duration of viral shedding and hospital stay in patients with mild to moderate…
RT @AbdTahrani: Early triple antiviral therapy shortened the duration of viral shedding and hospital stay in patients with mild to moderate…
RT @JorgeMTamayo: Terapia triple con interferon beta-1b, lopinavir–ritonavir (L-R) y ribavirina fue segura y superior al L-R solo para redu…
RT @AbdTahrani: Early triple antiviral therapy shortened the duration of viral shedding and hospital stay in patients with mild to moderate…
Terapia triple con interferon beta-1b, lopinavir–ritonavir (L-R) y ribavirina fue segura y superior al L-R solo para reducir los síntomas, la duración de la eliminación del virus y la estancia hospitalaria en pacientes con COVID-19 leve a moderada https://
RT @AbdTahrani: Early triple antiviral therapy shortened the duration of viral shedding and hospital stay in patients with mild to moderate…
Early triple antiviral therapy shortened the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19 @kamleshkhunti @drpatrickholmes @AmarPut @hazlehurst_j https://t.co/U8axmWsGli
IFNβ-1b、ロピナビル/リトナビル、リバビリンの3剤併用療法の方が、単剤療法より効果あるっぽい、という報告(PDFなので翻訳かけれない_(:o」∠)_ https://t.co/orENsJ79Mi
@SagittariusHH https://t.co/FrARRZIADH la trithérapie ?
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
JAJAJAJA
RT @biohussein: المصدر: https://t.co/xG5a1nDeEg
المصدر: https://t.co/xG5a1nDeEg
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet https://t.co/DKY0FBgrZj
RT @EricTopol: Very encouraging randomized trial results for interferon β-1b in mild to moderate #COVID19: marked reduction viral shedding,…
RT @EricTopol: Links and details for the 2 published trials https://t.co/OBWzhQrLPt https://t.co/AydJFDFGFF
TRIPLE combinación Tto COVID 19= -2 Antivirales(kaletra:lopinavir/ritonavir usado en Aids)+(ribavirina,usado en Hcc)ambos via oral. -1 Inmunomodulador(IFN beta-1b, uso en EM)en inyección sc. Pendiente ensayo fase 3a https://t.co/rF4ryfAi0a
RT @LaurelOld: @ASBMB Couple of recent reports: This study of 199ppl saw no benefit with lopinavir/ritonavir. https://t.co/hcxHE9MDt8. A st…
@ASBMB Couple of recent reports: This study of 199ppl saw no benefit with lopinavir/ritonavir. https://t.co/hcxHE9MDt8. A study of 127 ppl reported the same week suggests that triple therapy (L/R, ribavirin and IFNb) sped recovery faster than L/R alone htt
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
RT @carlomonkey1: @xsaezll La triple combinación de interferon beta-1b, lopinavir–ritonavir y ribavirin se ve prometedor. https://t.co/xvD…
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https://t.co/hgFh469909 Inhibidores del complemento: https://t.co/Ojr4vI0DW5 Tocilizumab: https://t.co/TA6F04clC7 Hidroxicloroquina: todos
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
RT @carlomonkey1: @xsaezll La triple combinación de interferon beta-1b, lopinavir–ritonavir y ribavirin se ve prometedor. https://t.co/xvD…
RT @carlomonkey1: @xsaezll La triple combinación de interferon beta-1b, lopinavir–ritonavir y ribavirin se ve prometedor. https://t.co/xvD…
RT @carlomonkey1: @xsaezll La triple combinación de interferon beta-1b, lopinavir–ritonavir y ribavirin se ve prometedor. https://t.co/xvD…
@xsaezll La triple combinación de interferon beta-1b, lopinavir–ritonavir y ribavirin se ve prometedor. https://t.co/xvDEdwuud9
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
RT @ABsteward: Early combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin was safe and superior to lopinavir–ritonavir alo…
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
@Taarikh_ @Conflits_FR Faux, la France comme les USA font un embargo contre le médoc de Cuba utilisé en Chine et dans 47 autres pays, médoc qui ne coûte rien. L'Interféron !! https://t.co/CqIaHuyncE
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
Trump's followers will want to take the potentially harmful drug he takes, hydroxychloroquine, to prevent or treat coronavirus disease. People infected with the virus should instead be treated with the drugs discussed in The Lancet. https://t.co/svshNN2Hf
RT @EricTopol: Very encouraging randomized trial results for interferon β-1b in mild to moderate #COVID19: marked reduction viral shedding,…
RT @ABsteward: Early combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin was safe and superior to lopinavir–ritonavir alo…
RT @ABsteward: Early combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin was safe and superior to lopinavir–ritonavir alo…
RT @ABsteward: Early combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin was safe and superior to lopinavir–ritonavir alo…
RT @DrJCarrielM: @Dr_Espino Revisa esto 👇 https://t.co/JJWE4DHgIW
MedTweetorial: #Tweetorial Author: @rbganatra Type: #Publication #Research Specialty: #InfectiousDisease #ID #InternalMedicine #IM Topics: #Lopinavir_Ritonavir #LPVr #Ribavirin #RBV) #Interferonbeta1b #IFN #SARSCoV2 #COVID19 #HowIReadThisPaper #TheLanc
@Dr_Espino Revisa esto 👇 https://t.co/JJWE4DHgIW
RT @hkumed: For more on the study in @TheLancet - Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treat…
RT @hkumed: For more on the study in @TheLancet - Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treat…
For more on the study in @TheLancet - Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/NN3qDa9WmR
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
@pianiste13 @SaraAl3jmi @biohussein أعتقد إعتمدو على هذه الدراسة في ال triple therapy https://t.co/XTS3et1uL2
@MartinAmora vos que pensás de este estudio? https://t.co/fbhborFOg3 Con todo el ruido que le hicieron a la cloriquina y derivados, con los resultados regulares de Remdesivir. Este coctel aparentemente reduce a 5 días de hospitalización y cuesta <US$50
The link to the Lancet article is https://t.co/NqJIXmv79l It does seem that Hong Kong had 80% of their #COVID__19 #COVID cases consented to that study and credited rapid identification and treatment with the low death rate. A guide? @VPrasadMDMPH
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
Early triple combination antiviral therapy interferon BETA-1b, lopinavir/ritonavir, ribavirin, alleviating symptoms, shortening the duration of viral shedding/hospital stay in mild-moderate Covid19 https://t.co/nIbVo3BbqJ
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
RT @rplenge: In an open-label, randomized Ph2 trial of n=127 COVID-19 patients, IFN-beta-1b (as part of triple therapy) was found to allevi…
RT @rbganatra: 1/ Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19?…
RT @ccarballo50: Último tweet optimista: Efecto beneficioso claro del tratamiento con triple terapia administrada en los 7 días tras el ini…